Grosmaire, Laura Sue,Hayden-Ledbetter, Martha Susan,Ledbetter, Jeffrey A.,Thompson, Peter Armstrong,Simon, Sandy Alexander,BRADY, William
申请号：
HUE10181126
公开号：
HUE026303T2
申请日:
2006.07.25
申请国别(地区):
HU
年份:
2016
代理人:
摘要：
The present disclosure generally provides methods for B-cell reduction in an individual using CD37-specific binding molecules. In particular, the disclosure provides methods for B-cell reduction using CD37-specific binding molecules alone, or a combination of CD37-specific binding molecules and CD20-specific binding molecules, in some instances a synergistic combination. The application further provides materials and methods for treatment of diseases involving aberrant B-cell activity. In addition, the disclosure provides humanized CD37-specific binding molecules.
